vs

Side-by-side financial comparison of ANAVEX LIFE SCIENCES CORP. (AVXL) and Ivanhoe Electric Inc. (IE). Click either name above to swap in a different company.

ANAVEX LIFE SCIENCES CORP. is the larger business by last-quarter revenue ($1.1M vs $896.0K, roughly 1.2× Ivanhoe Electric Inc.). ANAVEX LIFE SCIENCES CORP. runs the higher net margin — -526.5% vs -4500.4%, a 3973.9% gap on every dollar of revenue. On growth, ANAVEX LIFE SCIENCES CORP. posted the faster year-over-year revenue change (-22.6% vs -32.7%). Over the past eight quarters, Ivanhoe Electric Inc.'s revenue compounded faster (57.8% CAGR vs -21.6%).

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical firm focused on developing novel small molecule therapeutics for neurodegenerative and neurodevelopmental disorders such as Alzheimer’s disease, Rett syndrome and Parkinson’s disease. It operates mainly across North America and European markets, targeting patients with high unmet medical needs.

Ivanhoe Electric Inc. is a critical minerals exploration and development firm focused on metals for global electrification. It targets high-grade copper, gold, silver and strategic deposits, with primary North American operations, supplying raw materials to renewable energy, EV and power grid infrastructure supply chains worldwide.

AVXL vs IE — Head-to-Head

Bigger by revenue
AVXL
AVXL
1.2× larger
AVXL
$1.1M
$896.0K
IE
Growing faster (revenue YoY)
AVXL
AVXL
+10.1% gap
AVXL
-22.6%
-32.7%
IE
Higher net margin
AVXL
AVXL
3973.9% more per $
AVXL
-526.5%
-4500.4%
IE
Faster 2-yr revenue CAGR
IE
IE
Annualised
IE
57.8%
-21.6%
AVXL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AVXL
AVXL
IE
IE
Revenue
$1.1M
$896.0K
Net Profit
$-5.7M
$-40.3M
Gross Margin
69.5%
Operating Margin
-628.5%
-4167.7%
Net Margin
-526.5%
-4500.4%
Revenue YoY
-22.6%
-32.7%
Net Profit YoY
53.1%
-318.3%
EPS (diluted)
$-0.06
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVXL
AVXL
IE
IE
Q4 25
$1.1M
$896.0K
Q3 25
$999.0K
$545.0K
Q2 25
$1.1M
$1.1M
Q1 25
$1.2M
$735.0K
Q4 24
$1.4M
$1.3M
Q3 24
$1.8M
$671.0K
Q2 24
$1.8M
$538.0K
Q1 24
$1.8M
$360.0K
Net Profit
AVXL
AVXL
IE
IE
Q4 25
$-5.7M
$-40.3M
Q3 25
$-9.8M
$-17.5M
Q2 25
$-13.2M
$-23.9M
Q1 25
$-11.2M
$-34.1M
Q4 24
$-12.1M
$18.5M
Q3 24
$-11.6M
$-43.2M
Q2 24
$-12.2M
$-46.8M
Q1 24
$-10.5M
$-60.1M
Gross Margin
AVXL
AVXL
IE
IE
Q4 25
69.5%
Q3 25
51.2%
Q2 25
72.5%
Q1 25
60.1%
Q4 24
64.7%
Q3 24
61.8%
Q2 24
64.3%
Q1 24
72.2%
Operating Margin
AVXL
AVXL
IE
IE
Q4 25
-628.5%
-4167.7%
Q3 25
-1085.5%
-4328.3%
Q2 25
-1345.0%
-2400.3%
Q1 25
-1034.1%
-3674.0%
Q4 24
-975.0%
-2229.4%
Q3 24
-810.9%
-6233.8%
Q2 24
-813.1%
-9023.4%
Q1 24
-718.9%
-15800.3%
Net Margin
AVXL
AVXL
IE
IE
Q4 25
-526.5%
-4500.4%
Q3 25
-983.7%
-3214.9%
Q2 25
-1231.9%
-2233.2%
Q1 25
-925.3%
-4645.0%
Q4 24
-868.8%
1386.6%
Q3 24
-660.2%
-6443.5%
Q2 24
-680.1%
-8695.7%
Q1 24
-600.6%
-16693.1%
EPS (diluted)
AVXL
AVXL
IE
IE
Q4 25
$-0.06
$0.24
Q3 25
$-0.11
$0.13
Q2 25
$-0.16
$0.18
Q1 25
$-0.13
$0.24
Q4 24
$-0.14
$-0.14
Q3 24
$-0.14
$0.36
Q2 24
$-0.14
$0.39
Q1 24
$-0.13
$0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVXL
AVXL
IE
IE
Cash + ST InvestmentsLiquidity on hand
$131.7M
$173.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$126.6M
$416.1M
Total Assets
$133.0M
$483.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVXL
AVXL
IE
IE
Q4 25
$131.7M
$173.3M
Q3 25
$102.6M
$69.5M
Q2 25
$101.2M
$88.0M
Q1 25
$115.8M
$98.2M
Q4 24
$120.8M
$41.0M
Q3 24
$132.2M
$81.1M
Q2 24
$138.8M
$133.8M
Q1 24
$139.4M
$179.4M
Stockholders' Equity
AVXL
AVXL
IE
IE
Q4 25
$126.6M
$416.1M
Q3 25
$94.9M
$280.1M
Q2 25
$91.0M
$293.3M
Q1 25
$99.8M
$307.0M
Q4 24
$110.9M
$268.6M
Q3 24
$120.3M
$250.1M
Q2 24
$129.8M
$289.2M
Q1 24
$135.0M
$331.5M
Total Assets
AVXL
AVXL
IE
IE
Q4 25
$133.0M
$483.3M
Q3 25
$103.8M
$386.2M
Q2 25
$102.4M
$400.5M
Q1 25
$117.1M
$414.4M
Q4 24
$124.0M
$374.9M
Q3 24
$135.6M
$375.4M
Q2 24
$141.5M
$416.3M
Q1 24
$144.5M
$461.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVXL
AVXL
IE
IE
Operating Cash FlowLast quarter
$-7.2M
$-25.7M
Free Cash FlowOCF − Capex
$-25.7M
FCF MarginFCF / Revenue
-2872.8%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-90.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVXL
AVXL
IE
IE
Q4 25
$-7.2M
$-25.7M
Q3 25
$-8.6M
$-27.7M
Q2 25
$-12.5M
$-20.0M
Q1 25
$-5.9M
$-15.8M
Q4 24
$-12.1M
$-30.7M
Q3 24
$-6.7M
$-36.9M
Q2 24
$-5.2M
$-44.5M
Q1 24
$-11.7M
$-50.0M
Free Cash Flow
AVXL
AVXL
IE
IE
Q4 25
$-25.7M
Q3 25
$-27.8M
Q2 25
$-21.3M
Q1 25
$-15.8M
Q4 24
$-32.4M
Q3 24
$-36.9M
Q2 24
$-45.0M
Q1 24
$-50.6M
FCF Margin
AVXL
AVXL
IE
IE
Q4 25
-2872.8%
Q3 25
-5103.9%
Q2 25
-1990.1%
Q1 25
-2146.5%
Q4 24
-2432.4%
Q3 24
-5506.6%
Q2 24
-8372.9%
Q1 24
-14064.2%
Capex Intensity
AVXL
AVXL
IE
IE
Q4 25
4.1%
Q3 25
16.9%
Q2 25
117.6%
Q1 25
0.3%
Q4 24
127.3%
Q3 24
8.8%
Q2 24
93.7%
Q1 24
186.7%
Cash Conversion
AVXL
AVXL
IE
IE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-1.66×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons